- Home
- Publications
- Publication Search
- Publication Details
Title
Alzheimer’s Disease: Advances in Drug Development
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-11
Publisher
IOS Press
Online
2018-07-18
DOI
10.3233/jad-180145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease
- (2018) M. Casati et al. EUROPEAN JOURNAL OF NEUROLOGY
- IL12/23 p40 Inhibition Ameliorates Alzheimer's Disease-Associated Neuropathology and Spatial Memory in SAMP8 Mice
- (2018) Meng-Shan Tan et al. JOURNAL OF ALZHEIMERS DISEASE
- An update on the advancements in the treatment of agitation in Alzheimer’s disease
- (2017) Anton P. Porsteinsson et al. EXPERT OPINION ON PHARMACOTHERAPY
- BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides
- (2017) Kei Sakamoto et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease
- (2017) Natalia Mast et al. NEUROPHARMACOLOGY
- PKR involvement in Alzheimer’s disease
- (2017) Jacques Hugon et al. Alzheimers Research & Therapy
- Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms
- (2017) Kristina Endres et al. Frontiers in Molecular Neuroscience
- Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults
- (2017) Mark A. Reger et al. JOURNAL OF ALZHEIMERS DISEASE
- Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease
- (2016) Malcolm A. Leissring CNS DRUGS
- Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models
- (2016) Lingzhi Zhao et al. NEUROBIOLOGY OF AGING
- Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model
- (2015) Romain Fol et al. ACTA NEUROPATHOLOGICA
- Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease
- (2015) L.M. Schrott et al. Current Alzheimer Research
- A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
- (2015) Ulf Neumann et al. Molecular Neurodegeneration
- Invited review: Drug development for tauopathies
- (2015) Fiona Grüninger NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Lessons from a BACE1 inhibitor trial: Off-site but not off base
- (2014) Debomoy K. Lahiri et al. Alzheimers & Dementia
- Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward
- (2014) Francesco Panza et al. Expert Review of Clinical Immunology
- Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
- (2014) Robert Wyse et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Amyloid-ß-directed immunotherapy for Alzheimer's disease
- (2014) L. Lannfelt et al. JOURNAL OF INTERNAL MEDICINE
- Targeting the β secretase BACE1 for Alzheimer's disease therapy
- (2014) Riqiang Yan et al. LANCET NEUROLOGY
- Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models
- (2014) Mathew Blurton-Jones et al. Stem Cell Research & Therapy
- BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
- (2014) Robert Vassar Alzheimers Research & Therapy
- γ-Secretase inhibitors and modulators
- (2013) Todd E. Golde et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice
- (2013) Sandra Sivilia et al. BMC NEUROSCIENCE
- Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial
- (2013) H. Davtyan et al. JOURNAL OF NEUROSCIENCE
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intracranial Injection of AAV Expressing NEP but Not IDE Reduces Amyloid Pathology in APP+PS1 Transgenic Mice
- (2013) Nikisha Carty et al. PLoS One
- Mesenchymal Stem Cells Stimulate Endogenous Neurogenesis in the Subventricular Zone of Adult Mice
- (2010) Inna Kan et al. Stem Cell Reviews and Reports
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
- (2009) M. Blurton-Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice
- (2008) Niki C Carty et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started